MULPLETA

Peak

lusutrombopag

NDAORALTABLETPriority Review

Approved

Jul 2018

Lifecycle

Peak

Competitive Pressure

0/100

Mechanism of Action

bioavailable, small molecule TPO receptor agonist that interacts with the transmembrane domain of human TPO receptors expressed on megakaryocytes to induce the proliferation and differentiation of megakaryocytic progenitor cells from hematopoietic stem cells and megakaryocyte maturation.